Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Eversole A, Imran R, Gaitan N, Cobb CO, Barnes AJ, Halquist M, Hayes RB, Lipato T, Eissenberg T, Breland A. Physiological and subjective effects of an oral nicotine pouch in people who use smokeless tobacco. Exp Clin Psychopharmacol. 2025 Oct; 33(5):483-493.
-
Tang N, Zhang J, Liu X, Yao D, Zhang X, Ye P, Liu T, Liang J, Yang W, Armstrong E, Mitchell P, Ivers R, Wong RMY, Wang Y, Yang M, Tian M. Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis. Osteoporos Int. 2025 Aug; 36(8):1347-1357.
-
Meinel TR, B?cke P, D'Anna L, Merlino G, Aguiar de Sousa D, Poli S, Purrucker JC, Strambo D, Romoli M, De Marchis GM, Pfeilschifter W, Zedde M, Marto JP, Candelaresi P, Lemmens R, Scoppettuolo P, Woock M, Kermer P, Kristoffersen ES, Ghannam M, Frol S, Nolte CH, Yakushiji Y, Touz? E, Uphaus T, Mannino M, Ntaios G, Padjen V, Henninger N, Zipser-Mohammadzada F, Mariano ME, Guerreiro C, Burini A, Ceccarelli L, Valente M, Gomez-Exposito A, Kleeberg A, Thevoz G, Michel P, Stufano G, Vlachos D, Herrmann M, Rodrigues B, Spina E, Andreone V, Allardt A, Alshaer QN, Riegler C, Kunieda T, Boulanger M, Hahn M, Papadimitriou D, Muppa J, Maes L, Ranta A, Tyson A, Barber PA, Davis AJ, Wu TY, Kaesmacher J, Fischer U, Seiffge DJ. Intravenous Thrombolysis in Patients With Recent Intake of Direct Oral Anticoagulants: A Target Trial Analysis and Comparison With Reversal Agent Use. Stroke. 2025 Oct; 56(10):2836-2845.
-
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Clerisme-Beaty E, Coeck C, Gu H, Ritter I, Schlosser A, Stowasser S, Voss F, Weimann G, Zoz DF, Martinez FJ. Nerandomilast in Patients with Progressive Pulmonary Fibrosis. N Engl J Med. 2025 Jun 12; 392(22):2203-2214.
-
O'Mahony ET, Arian CM, Aryeh KS, Wang K, Thummel KE, Kelly EJ. Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy. Pharmacol Ther. 2025 Sep; 273:108879.
-
Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Clerisme-Beaty E, Gordat M, Wachtlin D, Liu Y, Schlecker C, Stowasser S, Zoz DF, Wijsenbeek MS. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med. 2025 Jun 12; 392(22):2193-2202.
-
Sheen S, Choo J, Huh B, Chung M. The effect of oral methadone on the QTc interval in cancer pain patients. Pain Manag. 2025 Jan; 15(1):21-25.
-
Arian C, O'Mahony E, MacDonald JW, Bammler TK, Donowitz M, Kelly EJ, Thummel KE. Human enteroid monolayers: A novel, functionally stable model for investigating oral drug disposition. Drug Metab Dispos. 2025 Jan; 53(1):100002.
-
Ezenna C, Pereira V, Abozenah M, Franco AJ, Gbegbaje O, Zaidi A, Krishna MM, Joseph M, Ramesh P, Chalhoub F. Perioperative direct oral anticoagulant management during cardiac implantable electronic device surgery: an updated systematic review and meta-analysis. J Interv Card Electrophysiol. 2025 Jun; 68(4):845-856.
-
Liu L, McClements DJ, Liu X, Liu F. Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients. Adv Sci (Weinh). 2024 Nov; 11(44):e2401172.